Clinical & Diagnostic
MINJUVI® (tafasitamab) provisionally approved by Therapeutic Goods Administration[1] Recent five-year follow-up data from Phase 2 L-MIND investig...
June 28, 2023 | News
INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...
June 28, 2023 | News
The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland Chi...
June 27, 2023 | News
- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...
June 26, 2023 | News
Cognigenics CEO John L. Mee announces breakthrough results from an animal study published today in PNAS Nexus. The findings point to the pot...
June 23, 2023 | Analysis
Dr. Jo White evaluated Xafty's clinical results as "The birth of Penicillin of Antivirals" and "a groundbreaking achievement that suggests a so...
June 19, 2023 | News
For the first time ever in Southeast Asia, the 25th World Congress of Dermatology (WCD2023) will take place in Singapore at S...
June 16, 2023 | News
The ASEAN region has witnessed a significant increase in dengue cases and is considered the global epicenter of dengue infections With more th...
June 15, 2023 | News
The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-inco...
June 15, 2023 | News
The collaboration will consist of the joint development of syndromic qPCR assays suitable for the Spanish and Portuguese healthcare systems, including assa...
June 15, 2023 | News
It is an IVD product that can be used with Bio-Rad's Droplet Digital PCR instrument and has also obtained CE certification in Europe last year. ...
June 14, 2023 | News
HanAll Biopharma and Daewoong Pharmaceutical have co-invested in Vincere Biosciences. These mission-aligned companies are collaborating to develop small...
June 13, 2023 | News
Revvity, Inc. (NYSE: RVTY), announced that its EUROIMMUN business has launched the UNIQO 160 (CE-IVDR), an automated indirec...
June 07, 2023 | News
The FDA Orphan Drug Designation program grants orphan status to promising investigation drugs or biological products designed to treat, prevent or diagnose...
June 07, 2023 | News
Most Read
Bio Jobs
News